12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers

  • Revelation Biosciences REVB stock moved upwards by 30.0% to $2.0 during Tuesday's after-market session. Today's trading volume for this security ended up closing at 574.9K shares, which is 133.3 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $28.4 million.
  • NeuBase Therapeutics NBSE shares moved upwards by 15.07% to $1.45. The company's market cap stands at $47.5 million.
  • Hims & Hers Health HIMS shares increased by 11.9% to $4.7. Today's trading volume for this security ended up closing at 1.2 million shares, which is 54.9 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $963.5 million. The company's, Q4 earnings came out today.
  • Virpax Pharmaceuticals VRPX shares increased by 11.27% to $2.27. The market value of their outstanding shares is at $26.5 million.
  • BioCardia BCDA shares increased by 9.09% to $2.4. The market value of their outstanding shares is at $40.4 million.
  • Biocept BIOC shares increased by 7.55% to $2.42. The market value of their outstanding shares is at $40.7 million.

Losers

  • Ocugen OCGN shares decreased by 14.4% to $3.62 during Tuesday's after-market session. This security traded at a volume of 5.6 million shares come close, making up 43.9% of its average volume over the last 100 days. The company's market cap stands at $721.0 million.
  • Marinus Pharmaceuticals MRNS shares decreased by 12.53% to $9.78. The company's market cap stands at $359.5 million.
  • Avenue Therapeutics ATXI shares fell 6.13% to $0.22. Trading volume for this security closed at 52.2K, accounting for 8.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $4.6 million.
  • Teladoc Health TDOC stock declined by 6.05% to $61.35. At the close, Teladoc Health's trading volume reached 1.1 million shares. This is 25.7% of its average volume over the last 100 days. The company's market cap stands at $9.8 billion. As per the press release, Q4 earnings came out today.
  • Medigus MDGS shares declined by 4.55% to $1.05. The market value of their outstanding shares is at $25.0 million.
  • Qualigen Therapeutics QLGN shares fell 4.13% to $0.66. The market value of their outstanding shares is at $23.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-TFMMovers